{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T07:59:52Z","timestamp":1794038392174,"version":"4.8.0"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,5,26]],"date-time":"2017-05-26T00:00:00Z","timestamp":1495756800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2017,5,26]],"date-time":"2017-05-26T00:00:00Z","timestamp":1495756800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01AG049508"],"award-info":[{"award-number":["U01AG049508"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01AG052411"],"award-info":[{"award-number":["U01AG052411"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007457","name":"JPB Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007457","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["RF1AG054011"],"award-info":[{"award-number":["RF1AG054011"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13024-017-0184-x","type":"journal-article","created":{"date-parts":[[2017,5,26]],"date-time":"2017-05-26T13:49:49Z","timestamp":1495806589000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":545,"title":["Late onset Alzheimer\u2019s disease genetics implicates microglial pathways in disease risk"],"prefix":"10.1186","volume":"12","author":[{"given":"Anastasia G.","family":"Efthymiou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison M.","family":"Goate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,26]]},"reference":[{"key":"184_CR1","doi-asserted-by":"crossref","unstructured":"Alzheimer\u2019s Association. 2016 Alzheimer\u2019s Disease Facts and Figures. Alzheimers Dement. 2016;12(4).","DOI":"10.1016\/j.jalz.2016.03.001"},{"key":"184_CR2","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/349704a0","volume":"349","author":"A Goate","year":"1991","unstructured":"Goate A, et al. Segregation of a missense mutation in the amyloid precursor protein. Lett to Nat. 1991;349:704\u20136.","journal-title":"Lett to Nat"},{"key":"184_CR3","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/375754a0","volume":"375","author":"R Sherrington","year":"1995","unstructured":"Sherrington R, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer\u2019s disease. Nature. 1995;375:754\u201360.","journal-title":"Nature"},{"key":"184_CR4","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/ng1095-219","volume":"11","author":"Alzheimer\u2019s Disease Collaborative Group","year":"1995","unstructured":"Alzheimer\u2019s Disease Collaborative Group. The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families. Nat Genet. 1995;11:219\u201322.","journal-title":"Nat Genet"},{"key":"184_CR5","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/376775a0","volume":"376","author":"EI Rogaev","year":"1995","unstructured":"Rogaev EI, et al. Familial Alzheimer\u2019s disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer\u2019s disease type 3 gene. Nature. 1995;376:775\u20138.","journal-title":"Nature"},{"key":"184_CR6","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1126\/science.7638622","volume":"269","author":"AE Levy-lahad","year":"1995","unstructured":"Levy-lahad AE, et al. Candidate gene for the chromosome 1 familial Alzheimer\u2019s Disease Locus. Science. 1995;269:973\u20137.","journal-title":"Science"},{"key":"184_CR7","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.neurobiolaging.2010.03.025","volume":"33","author":"RJ Guerreiro","year":"2012","unstructured":"Guerreiro RJ, Gustafson DR, Hardy J. The genetic architecture of Alzheimer\u2019s disease: Beyond APP, PSENS and APOE. Neurobiol Aging. 2012;33:437\u201356.","journal-title":"Neurobiol Aging"},{"key":"184_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA. Alzheimer\u2019s Disease: The Amyloid Cascade Hypothesis. Science. 1992;256:3\u20135.","journal-title":"Science."},{"key":"184_CR9","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder EH, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science. 1993;261:921\u20133.","journal-title":"Science"},{"key":"184_CR10","first-page":"8098","volume":"90","author":"WJ Strittmatter","year":"1993","unstructured":"Strittmatter WJ, et al. Binding of human apolipoprotein E to synthetic amyloid, B peptide: Isoform-specific effects and implications for late-onset Alzheimer disease. Med Sci. 1993;90:8098\u2013102.","journal-title":"Med Sci"},{"key":"184_CR11","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R. Views & reviews Clinical diagnosis of Alzheimer\u2019s disease. Neurology. 1984;34:939.","journal-title":"Neurology"},{"key":"184_CR12","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1126\/science.1197623","volume":"330","author":"KG Mawuenyega","year":"2010","unstructured":"Mawuenyega KG, et al. Decreased clearance of CNS beta-amyloid in Alzheimer\u2019s disease. Science. 2010;330:1774.","journal-title":"Science"},{"key":"184_CR13","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.bcp.2014.01.008","volume":"88","author":"KI Mosher","year":"2014","unstructured":"Mosher KI, Wyss-Coray T. Microglial dysfunction in brain aging and Alzheimer\u2019s disease. Biochem Pharmacol. 2014;88:594\u2013604.","journal-title":"Biochem Pharmacol"},{"key":"184_CR14","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s00281-015-0518-0","volume":"37","author":"M Gold","year":"2015","unstructured":"Gold M, El Khoury J. \u03b2-amyloid, microglia, and the inflammasome in Alzheimer\u2019s disease. Semin Immunopathol. 2015;37:607\u201311.","journal-title":"Semin Immunopathol"},{"key":"184_CR15","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.tins.2015.08.006","volume":"38","author":"SD Mhatre","year":"2015","unstructured":"Mhatre SD, Tsai CA, Rubin AJ, James ML, Andreasson KI. Microglial malfunction: the third rail in the development of Alzheimer\u2019s disease. Trends Neurosci. 2015;38:621\u201336.","journal-title":"Trends Neurosci"},{"key":"184_CR16","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.biopsych.2014.05.006","volume":"77","author":"CM Karch","year":"2015","unstructured":"Karch CM, Goate AM. Alzheimer\u2019s disease risk genes and mechanisms of disease pathogenesis. Biol Psychiatry. 2015;77:43\u201351.","journal-title":"Biol Psychiatry"},{"key":"184_CR17","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1001\/jama.2013.2973","volume":"309","author":"C Reitz","year":"2013","unstructured":"Reitz C, et al. Variants in the ATP-binding cassette and the risk of late-onset Alzheimer Disease. JAMA. 2013;309:1483\u201392.","journal-title":"JAMA"},{"key":"184_CR18","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/ni0702-611","volume":"3","author":"SA Tishkoff","year":"2002","unstructured":"Tishkoff SA, Williams SM. Genetic analysis of African populations: human evolution and complex disease. Nat Rev Genet. 2002;3:611\u201321.","journal-title":"Nat Rev Genet"},{"key":"184_CR19","doi-asserted-by":"crossref","unstructured":"Tosto G, Reitz C. Genome-wide association studies in Alzheimer\u2019s disease: a review topical collection on dementia. Curr Neurol Neurosci Rep. 2013;13:381.","DOI":"10.1007\/s11910-013-0381-0"},{"key":"184_CR20","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1093\/hmg\/ddm031","volume":"16","author":"A Grupe","year":"2007","unstructured":"Grupe A, et al. Evidence for novel susceptibility genes for late-onset Alzheimer\u2019s disease from a genome-wide association study of putative functional variants. Hum Mol Genet. 2007;16:865\u201373.","journal-title":"Hum Mol Genet"},{"key":"184_CR21","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/ng.439","volume":"41","author":"J-C Lambert","year":"2009","unstructured":"Lambert J-C, et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer\u2019s disease. Nat Genet. 2009;41:1088\u201393.","journal-title":"Nat Genet"},{"key":"184_CR22","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/ng.440","volume":"41","author":"D Harold","year":"2009","unstructured":"Harold D, et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer\u2019s disease. Nat Genet. 2009;41:1088\u201393.","journal-title":"Nat Genet"},{"key":"184_CR23","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/ng.801","volume":"43","author":"AC Naj","year":"2011","unstructured":"Naj AC, et al. Common variants at MS4A4\/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer\u2019s disease. Nat Genet. 2011;43:436\u201341.","journal-title":"Nat Genet"},{"key":"184_CR24","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ng.2802","volume":"45","author":"JC Lambert","year":"2013","unstructured":"Lambert JC, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease. Nat Genet. 2013;45:1452\u20138.","journal-title":"Nat Genet"},{"key":"184_CR25","doi-asserted-by":"publisher","unstructured":"Liu JZ, Erlich Y, Pickrell JK. Case \u2013 control association mapping by proxy using family history of disease. 2016. doi:\n                    10.1038\/ng.3766\n                    \n                  .","DOI":"10.1038\/ng.3766"},{"key":"184_CR26","unstructured":"Huang K, et al. A common allele lowers SPI1 expression in myeloid cells and delays age at onset for Alzheimer\u2019s disease. Nat Neurosci. 2017; in press."},{"key":"184_CR27","doi-asserted-by":"publisher","first-page":"13320","DOI":"10.1523\/JNEUROSCI.1224-13.2013","volume":"33","author":"M Malik","year":"2013","unstructured":"Malik M, et al. CD33 Alzheimer\u2019s risk-altering polymorphism, CD33 expression, and exon 2 splicing. J Neurosci. 2013;33:13320\u20135.","journal-title":"J Neurosci"},{"key":"184_CR28","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1126\/science.1249547","volume":"344","author":"T Raj","year":"2014","unstructured":"Raj T, et al. Polarization of the effects of autoimmune and neurodegenerative risk alleles in leukocytes. Science. 2014;344:519\u201323.","journal-title":"Science"},{"key":"184_CR29","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.imbio.2011.07.017","volume":"217","author":"H Crehan","year":"2012","unstructured":"Crehan H, et al. Complement receptor 1 (CR1) and Alzheimer\u2019s disease. Immunobiology. 2012;217:244\u201350.","journal-title":"Immunobiology"},{"key":"184_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050976","volume":"7","author":"CM Karch","year":"2012","unstructured":"Karch CM, et al. Expression of novel Alzheimer\u2019s disease risk genes in control and Alzheimer\u2019s disease brains. PLoS One. 2012;7:e50976.","journal-title":"PLoS One."},{"key":"184_CR31","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S0006-8993(97)00850-0","volume":"769","author":"Y Shen","year":"1997","unstructured":"Shen Y, Li R, McGeer EG, McGeer PL. Neuronal expression of mRNAs for complement proteins of the classical pathway in Alzheimer brain. Brain Res. 1997;769:391\u20135.","journal-title":"Brain Res"},{"key":"184_CR32","first-page":"2336","volume":"27","author":"RJ Pruim","year":"2011","unstructured":"Pruim RJ, et al. LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics. 2011;27:2336\u20137.","journal-title":"Bioinformatics"},{"key":"184_CR33","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1101\/gr.137323.112","volume":"22","author":"AP Boyle","year":"2012","unstructured":"Boyle AP, et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res. 2012;22:1790\u20137.","journal-title":"Genome Res"},{"key":"184_CR34","doi-asserted-by":"crossref","unstructured":"Iida BYK, Mornaghi R, Nussenzweig V. Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus. J Exp Med. 1982;155;1427\u201338.","DOI":"10.1084\/jem.155.5.1427"},{"key":"184_CR35","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.it.2015.08.008","volume":"36","author":"Y Wu","year":"2015","unstructured":"Wu Y, Dissing-olesen L, Macvicar BA, Stevens B. Microglia: dynamic mediators of synapse development and plasticity. Trends Immunol. 2015;36:605\u201313.","journal-title":"Trends Immunol"},{"key":"184_CR36","doi-asserted-by":"crossref","unstructured":"Klickstein LB, Barbashov SF, Liu T, Jack RM, Nicholson-weller A. Complement Receptor Type 1 ( CR1, CD35 ) Is a Receptor for C1q. 7. Immunity. 1997;345\u201355.","DOI":"10.1016\/S1074-7613(00)80356-8"},{"key":"184_CR37","volume-title":"beta-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain","author":"H Jiang","year":"2017","unstructured":"Jiang H, Burdick D, Glabe CC, Cotman CW, Tenner AJ. beta-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain. 2017."},{"key":"184_CR38","doi-asserted-by":"crossref","unstructured":"Cribbs DH, Velazquez CAP, Soreghan B, Glabe CG, Tenner AJ. Complement activation by cross-linked truncated and chimeric full-length -amyloid. 1997;8:3457\u201362.","DOI":"10.1097\/00001756-199711100-00009"},{"key":"184_CR39","unstructured":"Velazquez P, Cribbs DH, Poulos TL, Tenner AJ. Aspartate residue 7 in amyloid [beta]-protein is critical for classical complement pathway activation: Implications for Alzheimer\u2019s disease pathogenesis. Nature. 1997;3:77-9."},{"key":"184_CR40","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.nbd.2013.02.003","volume":"54","author":"H Crehan","year":"2013","unstructured":"Crehan H, Hardy J, Pocock J. Blockage of CR1 prevents activation of rodent microglia. Neurobiol Dis. 2013;54:139\u201349.","journal-title":"Neurobiol Dis"},{"key":"184_CR41","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/nature14252","volume":"518","author":"E Gjoneska","year":"2015","unstructured":"Gjoneska E, et al. Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer\u2019s disease. Nature. 2015;518:365\u20139.","journal-title":"Nature"},{"key":"184_CR42","first-page":"1","volume-title":"Personalized genetic assessment of age-associated Alzheimer\u2019s disease risk","author":"RS Desikan","year":"2016","unstructured":"Desikan RS, et al. Personalized genetic assessment of age-associated Alzheimer\u2019s disease risk; 2016. p. 1\u201329."},{"key":"184_CR43","doi-asserted-by":"publisher","first-page":"D917","DOI":"10.1093\/nar\/gkv1101","volume":"44","author":"FO Bagger","year":"2016","unstructured":"Bagger FO, et al. BloodSpot: a database of gene expression profiles and transcriptional programs for healthy and malignant haematopoiesis. Nucleic Acids Res. 2016;44:D917\u201324.","journal-title":"Nucleic Acids Res"},{"key":"184_CR44","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.neuron.2015.11.013","volume":"89","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, et al. Purification and characterization of progenitor and mature human astrocytes reveals transcriptional and functional differences with mouse. Neuron. 2016;89:37\u201353.","journal-title":"Neuron"},{"key":"184_CR45","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/icb.2015.48","volume":"94","author":"L Eon Kuek","year":"2016","unstructured":"Eon Kuek L, Leffler M, Mackay GA, Hulett MD. The MS4A family: counting past 1, 2 and 3. Immunol Cell Biol. 2016;94:11\u201323.","journal-title":"Immunol Cell Biol"},{"key":"184_CR46","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s002510100339","volume":"53","author":"Y Liang","year":"2001","unstructured":"Liang Y, Buckley TR, Tu L, Langdon SD, Tedder TF. Structural organization of the human MS4A gene cluster on Chromosome 11q12. Immunogenetics. 2001;53:357\u201368.","journal-title":"Immunogenetics"},{"key":"184_CR47","doi-asserted-by":"publisher","unstructured":"Ma J, Yu JT, Tan L. MS4A Cluster in Alzheimer\u2019s Disease. Mol Neurobiol. 2014;1240\u20138. doi:\n                    10.1007\/s12035-014-8800-z\n                    \n                  .","DOI":"10.1007\/s12035-014-8800-z"},{"key":"184_CR48","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/gm249","volume":"3","author":"C Ant\u00fanez","year":"2011","unstructured":"Ant\u00fanez C, et al. The membrane-spanning 4-domains, subfamily A (MS4A) gene cluster contains a common variant associated with Alzheimer\u2019s disease. Genome Med. 2011;3:33.","journal-title":"Genome Med"},{"key":"184_CR49","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/ng.803","volume":"43","author":"P Hollingworth","year":"2011","unstructured":"Hollingworth P, et al. Common variants at ABCA7, MS4A6A\/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer\u2019s disease. Nat Genet. 2011;43:429\u201335.","journal-title":"Nat Genet"},{"key":"184_CR50","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1007\/s00439-012-1154-6","volume":"131","author":"YL Deng","year":"2012","unstructured":"Deng YL, et al. The prevalence of CD33 and MS4A6A variant in Chinese Han population with Alzheimer\u2019s disease. Hum Genet. 2012;131:1245\u20139.","journal-title":"Hum Genet"},{"key":"184_CR51","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.jalz.2012.08.007","volume":"9","author":"L Tan","year":"2013","unstructured":"Tan L, et al. Association of GWAS-linked loci with late-onset Alzheimer\u2019s disease in a northern Han Chinese population. Alzheimers Dement. 2013;9:546\u201353.","journal-title":"Alzheimers Dement"},{"key":"184_CR52","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1091\/mbc.E14-07-1221","volume":"26","author":"G Cruse","year":"2015","unstructured":"Cruse G, et al. The CD20 homologue MS4A4 directs trafficking of KIT toward clathrin-independent endocytosis pathways and thus regulates receptor signaling and recycling. Mol Biol Cell. 2015;26:1711\u201327.","journal-title":"Mol Biol Cell"},{"key":"184_CR53","doi-asserted-by":"publisher","unstructured":"Greer PL, et al. A Family of non-GPCR chemosensors defines an alternative logic for Mammalian Olfaction. Cell. 2016; doi:\n                    10.1016\/j.cell.2016.05.001\n                    \n                  .","DOI":"10.1016\/j.cell.2016.05.001"},{"key":"184_CR54","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/mp.2015.23","volume":"21","author":"G Jun","year":"2016","unstructured":"Jun G, et al. A novel Alzheimer disease locus located near the gene encoding tau protein. Mol Psychiatry. 2016;21:108\u201317.","journal-title":"Mol Psychiatry"},{"key":"184_CR55","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1006\/bbrc.2000.2954","volume":"273","author":"WE Kaminski","year":"2000","unstructured":"Kaminski WE, et al. Identification of a novel human sterol-sensitive ATP-binding cassette transporter (ABCA7). Biochem Biophys Res Commun. 2000;273:532\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"184_CR56","doi-asserted-by":"publisher","first-page":"42906","DOI":"10.1074\/jbc.M307831200","volume":"278","author":"N Wang","year":"2003","unstructured":"Wang N, et al. ATP-binding Cassette Transporter A7 (ABCA7) Binds Apolipoprotein A-I and Mediates Cellular Phospholipid but Not Cholesterol Efflux. J Biol Chem. 2003;278:42906\u201312.","journal-title":"J Biol Chem"},{"key":"184_CR57","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1074\/jbc.M309888200","volume":"279","author":"S Abe-Dohmae","year":"2004","unstructured":"Abe-Dohmae S, et al. Human ABCA7 supports apolipoprotein-mediated release of cellular cholesterol and phospholipid to generate high density lipoprotein. J Biol Chem. 2004;279:604\u201311.","journal-title":"J Biol Chem"},{"key":"184_CR58","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.neulet.2013.09.058","volume":"556","author":"JB Vasquez","year":"2013","unstructured":"Vasquez JB, Fardo DW, Estus S. ABCA7 expression is associated with Alzheimer\u2019s disease polymorphism and disease status. Neurosci Lett. 2013;556:58\u201362.","journal-title":"Neurosci Lett"},{"key":"184_CR59","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/ng.3246","volume":"47","author":"S Steinberg","year":"2015","unstructured":"Steinberg S, et al. Loss-of-function variants in ABCA7 confer risk of Alzheimer\u2019s disease. Nat Genet. 2015;47:445\u20137.","journal-title":"Nat Genet"},{"key":"184_CR60","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13195-015-0154-x","volume":"7","author":"JL Del-Aguila","year":"2015","unstructured":"Del-Aguila JL, et al. Role of ABCA7 loss-of-function variant in Alzheimer\u2019s disease: a replication study in European-Americans. Alzheimers Res Ther. 2015;7:73.","journal-title":"Alzheimers Res Ther"},{"key":"184_CR61","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/S1474-4422(15)00133-7","volume":"14","author":"E Cuyvers","year":"2015","unstructured":"Cuyvers E, et al. Mutations in ABCA7 in a Belgian cohort of Alzheimer\u2019s disease patients: a targeted resequencing study. Lancet Neurol. 2015;14:814\u201322.","journal-title":"Lancet Neurol"},{"key":"184_CR62","doi-asserted-by":"publisher","unstructured":"Guennec K, Le et al. ABCA7 rare variants and Alzheimer disease risk. Neurology. 2016;1\u20134. doi:\n                    10.1212\/WNL.0000000000002627\n                    \n                  .","DOI":"10.1212\/WNL.0000000000002627"},{"key":"184_CR63","doi-asserted-by":"publisher","first-page":"e126","DOI":"10.1212\/NXG.0000000000000126","volume":"3","author":"M Allen","year":"2017","unstructured":"Allen M, et al. ABCA7 loss-of-function variants, expression, and neurologic disease risk. Neurol Genet. 2017;3:e126.","journal-title":"Neurol Genet"},{"key":"184_CR64","doi-asserted-by":"publisher","first-page":"24152","DOI":"10.1074\/jbc.M115.655076","volume":"290","author":"K Satoh","year":"2015","unstructured":"Satoh K, Abe-Dohmae S, Yokoyama S, St. George-Hyslop P, Fraser PE. ATP-binding cassette transporter A7 (ABCA7) loss of function alters Alzheimer amyloid processing. J Biol Chem. 2015;290:24152\u201365.","journal-title":"J Biol Chem"},{"key":"184_CR65","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1086\/342259","volume":"71","author":"J Paloneva","year":"2002","unstructured":"Paloneva J, et al. Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype. Am J Hum Genet. 2002;71:656\u201362.","journal-title":"Am J Hum Genet"},{"key":"184_CR66","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro R, et al. TREM2 Variants in Alzheimer\u2019s Disease. N Engl J Med. 2013;368:117\u201327.","journal-title":"N Engl J Med"},{"key":"184_CR67","doi-asserted-by":"publisher","unstructured":"Jonsson T, et al. Variant of TREM2 Associated with the Risk of Alzheimer\u2019s Disease. N Engl J Med. 121114152813005 (2012). doi:\n                    10.1056\/NEJMoa1211103\n                    \n                  .","DOI":"10.1056\/NEJMoa1211103"},{"key":"184_CR68","doi-asserted-by":"publisher","first-page":"17.e1","DOI":"10.1016\/j.neurobiolaging.2016.02.029","volume":"42","author":"T Jiang","year":"2016","unstructured":"Jiang T, et al. A rare coding variant in TREM2 increases risk for Alzheimer\u2019s disease in Han Chinese. Neurobiol Aging. 2016;42:17.e1\u2013217.e3.","journal-title":"Neurobiol Aging"},{"key":"184_CR69","doi-asserted-by":"publisher","first-page":"5838","DOI":"10.1093\/hmg\/ddu277","volume":"23","author":"SC Jin","year":"2014","unstructured":"Jin SC, et al. Coding variants in TREM2 increase risk for Alzheimer\u2019s disease. Hum Mol Genet. 2014;23:5838\u201346.","journal-title":"Hum Mol Genet"},{"key":"184_CR70","doi-asserted-by":"publisher","first-page":"243ra86","DOI":"10.1126\/scitranslmed.3009093","volume":"6","author":"G Kleinberger","year":"2014","unstructured":"Kleinberger G, et al. TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis. Sci Transl Med. 2014;6:243ra86.","journal-title":"Sci Transl Med"},{"key":"184_CR71","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.jalz.2014.12.009","volume":"11","author":"CM Lill","year":"2015","unstructured":"Lill CM, et al. The role of TREM2 R47H as a risk factor for Alzheimer\u2019s disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson\u2019s disease. Alzheimers Dement. 2015;11:1407\u201316.","journal-title":"Alzheimers Dement"},{"key":"184_CR72","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1016\/j.neurobiolaging.2013.05.001","volume":"34","author":"P Forabosco","year":"2013","unstructured":"Forabosco P, et al. Insights into TREM2 biology by network analysis of human brain gene expression data. Neurobiol Aging. 2013;34:2699\u2013714.","journal-title":"Neurobiol Aging"},{"key":"184_CR73","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13024-016-0137-9","volume":"11","author":"L Ma","year":"2016","unstructured":"Ma L, et al. Expression and processing analyses of wild type and p.R47H TREM2 variant in Alzheimer\u2019s disease brains. Mol Neurodegener. 2016;11:72.","journal-title":"Mol Neurodegener"},{"key":"184_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/eLife.20391","volume":"5","author":"DL Kober","year":"2016","unstructured":"Kober DL, et al. Neurodegenerative disease mutations in TREM2 reveal a functional surface and distinct loss-of-function mechanisms. elife. 2016;5:1\u201324.","journal-title":"elife"},{"key":"184_CR75","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.neuroscience.2014.09.050","volume":"302","author":"L Lue","year":"2015","unstructured":"Lue L, Schmitz C, Walker DG. What happens to microglial trem2 in alzheimer\u2019s disease: immunoregulatory turned into immunopathogenic? Neuroscience. 2015;302:138\u201350.","journal-title":"Neuroscience"},{"key":"184_CR76","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.neuron.2016.06.015","volume":"91","author":"FL Yeh","year":"2016","unstructured":"Yeh FL, Wang Y, Tom I, Gonzalez LC, Sheng M. TREM2 binds to apolipoproteins, including APOE and CLU\/APOJ, and thereby facilitates uptake of amyloid-beta by microglia. Neuron. 2016;91:328\u201340.","journal-title":"Neuron"},{"key":"184_CR77","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.cell.2015.01.049","volume":"160","author":"Y Wang","year":"2015","unstructured":"Wang Y, et al. TREM2 lipid sensing sustains the microglial response in an Alzheimer\u2019s disease model. Cell. 2015;160:1061\u201371.","journal-title":"Cell"},{"key":"184_CR78","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1084\/jem.20151948","volume":"213","author":"Y Wang","year":"2016","unstructured":"Wang Y, et al. TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques. J Exp Med. 2016;213:667\u201375.","journal-title":"J Exp Med"},{"key":"184_CR79","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.neuron.2013.04.014","volume":"78","author":"A Griciuc","year":"2013","unstructured":"Griciuc A, et al. Alzheimer\u2019s disease risk gene cd33 inhibits microglial uptake of amyloid beta. Neuron. 2013;78:631\u201343.","journal-title":"Neuron"},{"key":"184_CR80","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s12035-013-8536-1","volume":"49","author":"T Jiang","year":"2014","unstructured":"Jiang T, et al. CD33 in alzheimer\u2019s disease. Mol Neurobiol. 2014;49:529\u201335.","journal-title":"Mol Neurobiol"},{"key":"184_CR81","doi-asserted-by":"publisher","first-page":"ra38","DOI":"10.1126\/scisignal.2000500","volume":"3","author":"Q Peng","year":"2010","unstructured":"Peng Q, et al. TREM2- and DAP12-dependent activation of PI3K requires DAP10 and is inhibited by SHIP1. Sci Signal. 2010;3:ra38.","journal-title":"Sci Signal"},{"key":"184_CR82","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ng.2653","volume":"45","author":"GTEx Consortium, T","year":"2013","unstructured":"GTEx Consortium, T. Gte. The Genotype-Tissue Expression (GTEx) project. Nat Genet. 2013;45:580\u20135.","journal-title":"Nat Genet"},{"key":"184_CR83","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2013.03.030","volume":"153","author":"B Zhang","year":"2013","unstructured":"Zhang B, et al. Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer\u2019s disease. Cell. 2013;153:707\u201320.","journal-title":"Cell"},{"key":"184_CR84","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nrn.2016.7","volume":"17","author":"M Colonna","year":"2016","unstructured":"Colonna M, Wang Y. TREM2 variants: new keys to decipher Alzheimer disease pathogenesis. Nat Rev Neurosci. 2016;17:201\u20137.","journal-title":"Nat Rev Neurosci"},{"key":"184_CR85","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1004574","volume":"11","author":"WM Song","year":"2015","unstructured":"Song WM, Zhang B. Multiscale embedded gene co-expression network analysis. PLoS Comput Biol. 2015;11:e1004574.","journal-title":"PLoS Comput Biol."},{"key":"184_CR86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JAD-2010-1231","volume":"19","author":"MP Murphy","year":"2010","unstructured":"Murphy MP, LeVine H III. Alzheimer\u2019s disease and the beta-amyloid peptide. J Alzheimers Dis. 2010;19:1\u201317.","journal-title":"J Alzheimers Dis"},{"key":"184_CR87","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1093\/brain\/awv379","volume":"139","author":"A Olmos-Alonso","year":"2016","unstructured":"Olmos-Alonso A, et al. Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer\u2019s-like pathology. Brain. 2016;139:891\u2013907.","journal-title":"Brain"},{"key":"184_CR88","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1389-0344(01)00067-3","volume":"17","author":"JL Jankowsky","year":"2001","unstructured":"Jankowsky JL, et al. Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. Biomol Eng. 2001;17:157\u201365.","journal-title":"Biomol Eng"},{"key":"184_CR89","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/hmg\/ddh019","volume":"13","author":"JL Jankowsky","year":"2004","unstructured":"Jankowsky JL, et al. Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum Mol Genet. 2004;13:159\u201370.","journal-title":"Hum Mol Genet"},{"key":"184_CR90","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley H, et al. Intraneuronal \u03b2-Amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. J Neurosci. 2006;26:10129\u201340.","journal-title":"J Neurosci"},{"key":"184_CR91","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1093\/brain\/aww016","volume":"139","author":"EE Spangenberg","year":"2016","unstructured":"Spangenberg EE, et al. Eliminating microglia in Alzheimer\u2019s mice prevents neuronal loss without modulating amyloid-\u03b2 pathology. Brain. 2016;139:1265\u201381.","journal-title":"Brain"},{"key":"184_CR92","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.neuron.2013.05.007","volume":"78","author":"S Gandy","year":"2013","unstructured":"Gandy S, Heppner FL. Microglia as dynamic and essential components of the amyloid hypothesis. Neuron. 2013;78:575\u20137.","journal-title":"Neuron"},{"key":"184_CR93","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1096\/fj.10-176891","volume":"25","author":"E Cudaback","year":"2011","unstructured":"Cudaback E, Li X, Montine KS, Montine TJ, Keene CD. Apolipoprotein E isoform-dependent microglia migration. FASEB J. 2011;25:2082\u201391.","journal-title":"FASEB J"},{"key":"184_CR94","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/1742-2094-11-111","volume":"11","author":"GA Rodriguez","year":"2014","unstructured":"Rodriguez GA, Tai LM, LaDu MJ, Rebeck GW. Human APOE4 increases microglia reactivity at Abeta plaques in a mouse model of Abeta deposition. J Neuroinflammation. 2014;11:111.","journal-title":"J Neuroinflammation"},{"key":"184_CR95","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.cell.2014.12.019","volume":"160","author":"L Liu","year":"2015","unstructured":"Liu L, et al. Glial lipid droplets and ROS induced by mitochondrial defects promote neurodegeneration. Cell. 2015;160:177\u201390.","journal-title":"Cell"},{"key":"184_CR96","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1523\/JNEUROSCI.21-12-04183.2001","volume":"21","author":"D Pratic\u00f2","year":"2001","unstructured":"Pratic\u00f2 D, Uryu K, Leight S, Trojanoswki JQ, Lee VM-Y. Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer Amyloidosis. J Neurosci. 2001;21:4183\u20137.","journal-title":"J Neurosci"},{"key":"184_CR97","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nn.3599","volume":"17","author":"O Butovsky","year":"2014","unstructured":"Butovsky O, et al. Identification of a unique TGF-\u03b2-dependent molecular and functional signature in microglia. Nat Neurosci. 2014;17:131\u201343.","journal-title":"Nat Neurosci"},{"key":"184_CR98","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1084\/jem.20132477","volume":"211","author":"R Yamasaki","year":"2014","unstructured":"Yamasaki R, et al. Differential roles of microglia and monocytes in the inflamed central nervous system. J Exp Med. 2014;211:1533\u201349.","journal-title":"J Exp Med"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-017-0184-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13024-017-0184-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-017-0184-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T10:03:38Z","timestamp":1589537018000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-017-0184-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,26]]},"references-count":98,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["184"],"URL":"https:\/\/doi.org\/10.1186\/s13024-017-0184-x","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,26]]},"assertion":[{"value":"9 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"43"}}